116 related articles for article (PubMed ID: 26785814)
21. Remarkable difference of somatic mutation patterns between oncogenes and tumor suppressor genes.
Liu H; Xing Y; Yang S; Tian D
Oncol Rep; 2011 Dec; 26(6):1539-46. PubMed ID: 21887471
[TBL] [Abstract][Full Text] [Related]
22. Measuring single cell divisions in human tissues from multi-region sequencing data.
Werner B; Case J; Williams MJ; Chkhaidze K; Temko D; Fernández-Mateos J; Cresswell GD; Nichol D; Cross W; Spiteri I; Huang W; Tomlinson IPM; Barnes CP; Graham TA; Sottoriva A
Nat Commun; 2020 Feb; 11(1):1035. PubMed ID: 32098957
[TBL] [Abstract][Full Text] [Related]
23. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis.
Soussi T; Dehouche K; Béroud C
Hum Mutat; 2000; 15(1):105-13. PubMed ID: 10612830
[TBL] [Abstract][Full Text] [Related]
24. A compartment size-dependent selective threshold limits mutation accumulation in hierarchical tissues.
Grajzel D; Derényi I; Szöllősi GJ
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1606-1611. PubMed ID: 31907322
[TBL] [Abstract][Full Text] [Related]
25. The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection.
Yadav VK; DeGregori J; De S
Nucleic Acids Res; 2016 Mar; 44(5):2075-84. PubMed ID: 26883632
[TBL] [Abstract][Full Text] [Related]
26. Trade-off between reducing mutational accumulation and increasing commitment to differentiation determines tissue organization.
Demeter M; Derényi I; Szöllősi GJ
Nat Commun; 2022 Mar; 13(1):1666. PubMed ID: 35351889
[TBL] [Abstract][Full Text] [Related]
27. Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes.
Balestrieri C; Vanoni M; Hautaniemi S; Alberghina L; Chiaradonna F
Biotechnol Adv; 2012; 30(1):16-29. PubMed ID: 21736933
[TBL] [Abstract][Full Text] [Related]
28. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
[TBL] [Abstract][Full Text] [Related]
29. Carcinogenesis in Down syndrome: what can be learned from trisomy 21?
Satgé D; Bénard J
Semin Cancer Biol; 2008 Oct; 18(5):365-71. PubMed ID: 18455928
[TBL] [Abstract][Full Text] [Related]
30. An ordinary differential equation model for the multistep transformation to cancer.
Spencer SL; Berryman MJ; García JA; Abbott D
J Theor Biol; 2004 Dec; 231(4):515-24. PubMed ID: 15488528
[TBL] [Abstract][Full Text] [Related]
31. Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma.
Kloss-Brandstätter A; Weissensteiner H; Erhart G; Schäfer G; Forer L; Schönherr S; Pacher D; Seifarth C; Stöckl A; Fendt L; Sottsas I; Klocker H; Huck CW; Rasse M; Kronenberg F; Kloss FR
PLoS One; 2015; 10(8):e0135643. PubMed ID: 26262956
[TBL] [Abstract][Full Text] [Related]
32. Relationship of chromosome changes to neoplastic cell transformation.
DiPaolo JA; Popescu NC
Am J Pathol; 1976 Dec; 85(3):709-38. PubMed ID: 826168
[TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of germline and somatic microlesion mutational spectra in 17 human tumor suppressor genes.
Ivanov D; Hamby SE; Stenson PD; Phillips AD; Kehrer-Sawatzki H; Cooper DN; Chuzhanova N
Hum Mutat; 2011 Jun; 32(6):620-32. PubMed ID: 21432943
[TBL] [Abstract][Full Text] [Related]
34. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
35. Aneuploidy, the somatic mutation that makes cancer a species of its own.
Duesberg P; Rasnick D
Cell Motil Cytoskeleton; 2000 Oct; 47(2):81-107. PubMed ID: 11013390
[TBL] [Abstract][Full Text] [Related]
36. [Current topics in mutations in the cancer genome].
Iwaya T; Mimori K; Wakabayashi G
Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):185-90. PubMed ID: 22582578
[TBL] [Abstract][Full Text] [Related]
37. Methylation, mutation and cancer.
Jones PA; Rideout WM; Shen JC; Spruck CH; Tsai YC
Bioessays; 1992 Jan; 14(1):33-6. PubMed ID: 1546979
[TBL] [Abstract][Full Text] [Related]
38. An integrated analysis of cancer genes in thyroid cancer.
Chai L; Li J; Lv Z
Oncol Rep; 2016 Feb; 35(2):962-70. PubMed ID: 26718127
[TBL] [Abstract][Full Text] [Related]
39. TP53 and mutations in human cancer.
Szymańska K; Hainaut P
Acta Biochim Pol; 2003; 50(1):231-8. PubMed ID: 12673364
[TBL] [Abstract][Full Text] [Related]
40. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
